anti-Class II, Major Histocompatibility Complex, Transactivator (CIITA) Antibodies

CIITA encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. Additionally we are shipping Class II, Major Histocompatibility Complex, Transactivator Proteins (3) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
CIITA 12265 P79621
CIITA 4261 P33076
CIITA 85483  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Class II, Major Histocompatibility Complex, Transactivator Antibodies at antibodies-online.com

Showing 10 out of 50 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IHC (p), WB CIITA was detected in paraffin-embedded sections of human intestinal cancer tissues using rabbit anti- CIITA Antigen Affinity purified polyclonal antibody (Catalog # ) at 1 ??g/mL. The immunohistochemical section was developed using SABC method (Catalog # SA1022). CIITA was detected in paraffin-embedded sections of mouse spleen tissues using rabbit anti- CIITA Antigen Affinity purified polyclonal antibody (Catalog # ) at 1 µg/mL. The immunohistochemical section was developed using SABC method (Catalog # SA1022). 100 μg Log in to see 4 to 6 Days
$280.00
Details
Cow Rabbit Un-conjugated WB WB Suggested Anti-CIITA Antibody Titration:  0.2-1 ug/ml  ELISA Titer:  1:62500  Positive Control:  Human Liver 100 μL Log in to see 2 to 3 Days
$289.00
Details
Dog Rabbit Un-conjugated WB WB Suggested Anti-C2TA Antibody Titration:  0.125ug/ml  ELISA Titer:  1:62500  Positive Control:  NIH/3T3 cell lysate 100 μL Log in to see 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated ELISA, WB Western blot analysis of extracts from K562 cells, using CIITA Antibody. The lane on the right is treated with the synthesized peptide. 100 μg Log in to see 2 to 3 Days
$302.50
Details
Dog Rabbit Un-conjugated WB 50 μg Log in to see 7 to 9 Days
$551.83
Details
Cow Rabbit Un-conjugated WB 50 μg Log in to see 7 to 9 Days
$551.83
Details
Human Rabbit Un-conjugated ELISA, ICC, IF, WB ABIN6274235 staining Hela cells by IF/ICC. The sample were fixed with PFA and permeabilized in 0.1% Triton X-100,then blocked in 10% serum for 45 minutes at 25°C. The primary antibody was diluted at 1/200 and incubated with the sample for 1 hour at 37°C. An Alexa Fluor 594 conjugated goat anti-rabbit IgG (H+L) antibody(Cat.# S0006), diluted at 1/600, was used as secondary antibody. Western blot analysis of extracts from K562 cells, using CIITA antibody. 100 μL Log in to see 11 to 12 Days
$390.77
Details
Human Rabbit Un-conjugated ELISA, IHC, IHC (p), WB Human Tonsil: Formalin-Fixed, Paraffin-Embedded (FFPE) Anti-CIITA antibody IHC of human tonsil. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml. 50 μg Log in to see 11 to 14 Days
$484.00
Details
Human Rabbit Un-conjugated ELISA, WB 100 μL Log in to see 7 to 9 Days
$639.83
Details
Human Rabbit Un-conjugated IP   0.1 mL Log in to see 6 to 8 Days
$533.50
Details

Top referenced anti-Class II, Major Histocompatibility Complex, Transactivator Antibodies

  1. Pig (Porcine) Polyclonal CIITA Primary Antibody for WB - ABIN97339 : Koues, Dudley, Mehta, Greer: The 19S proteasome positively regulates histone methylation at cytokine inducible genes. in Biochimica et biophysica acta 2009 (PubMed)

  2. Human Polyclonal CIITA Primary Antibody for IHC (p), WB - ABIN4886541 : Sun, Huang, Yu, Zhang, Xu, Zhang, Li, Dong, Guo, Wang: Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation. in Cell death & disease 2016 (PubMed)

More Antibodies against Class II, Major Histocompatibility Complex, Transactivator Interaction Partners

Mouse (Murine) Class II, Major Histocompatibility Complex, Transactivator (CIITA) interaction partners

  1. study found that CIITA exerts a highly restricted control over only the MHCII, H2-DO and H2-DM genes, in DC1 and DC2 (show OSTC Antibodies) cDC (show CDK1 Antibodies) subsets, but not over other proposed targets

  2. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC (show MSC Antibodies) implantation on myocardial repair.

  3. M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promoter, thereby repressing its expression through NO and p38 MAPK (show MAPK14 Antibodies) activation

  4. this study shows that genetic polymorphisms in the type I promoter of C2ta regulate MHC-II expression and T-cell responses but do not necessarily have a strong impact on autoimmune diseases

  5. CIITA interacted with and recruited PRMT5 to the MHC II promoter and mediated the synergy between PRMT5 and ASH2/WDR5 to activate MHC II transcription

  6. NLRC5 (show NLRC5 Antibodies) and CIITA thus emerge as paradigms for a novel class of transcriptional regulators dedicated for transactivating extremely few, phylogenetically related genes.

  7. Data suggest that class II transactivator CIITA expression is likely mediated in hematopoietic cells by common elements with promoter accessibility having a part in promoter choice.

  8. Transfection of CIITA in poorly immunogenic PDA cells resulted in increased expression levels of the MHC class II molecule. CIITA-tumor cells were rejected in 80% to 100% of injected mice.

  9. IFN-gamma exerts a critical anti-inflammatory function in the intestine which protects against colitis by inducing MHCII expression on intestinal epithelial cells.

  10. tumor cell lines with a defective expression of CIITA transcripts lack MHC class II expression

Human Class II, Major Histocompatibility Complex, Transactivator (CIITA) interaction partners

  1. CIITA expression is higher when carried by FP single recombinants than when combined with FPgp or FPenv constructs and can induce HLA-DR cell surface expression. However, in-vivo experiments did not show any significant increase in the humoral response. As CIITA already proved to elicit immunogenicity by improving antigen presentation, further in-vivo experiments should be performed to increase the immune responses

  2. Therefore, our data identify HIC1 (show HIC1 Antibodies) as a novel factor involved in B cell differentiation acting as an epigenetic repressor of CIITA transcription.

  3. B. abortus lipoproteins via IL-6 (show IL6 Antibodies) inhibit the expression of IFN regulatory factor 1 (IRF-1 (show IRF1 Antibodies)), a critical regulatory transcription factor for CIITA induction.

  4. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC (show MSC Antibodies) implantation on myocardial repair.

  5. Brazilian Amerindian ancestry compared to Asian, European, and African Genomes.SNPs within or proximal to CIITA (rs6498115), SMC6 (show SMC6 Antibodies) (rs1834619), and KLHL29 (rs2288697) were most differentiated in the Amerindian-specific branch. SNPs in ADAMTS9 (show ADAMTS9 Antibodies) (rs7631391), DOCK2 (show DOCK2 Antibodies) (rs77594147), SLC28A1 (show SLC28A1 Antibodies) (rs28649017), ARHGAP5 (show ARHGAP5 Antibodies) (rs7151991), and CIITA (rs45601437) in the Asian comparison.

  6. CLPTM1L (show CLPTM1L Antibodies) and TERT (show TERT Antibodies) have been implicated in cancers, and CIITA is considered as the "master control factor" for the expression of NPC (show NPC1 Antibodies)-associated MHC class II (show HLA-DPA1 Antibodies) genes. These suggested that both SNPs might be functional. Altogether, our findings expand our understanding of the genetic contribution to NPC (show NPC1 Antibodies) risk and provide novel biological insights into NPC (show NPC1 Antibodies) pathogenesis.

  7. When mouse pDCs and CAL-1 cells were stimulated by GM-CSF, mRNA levels of PU.1, pIII-driven CIITA, total CIITA, MHC class II, and the amount of PU.1 binding to pIII were significantly increased

  8. the MHC2TA -168 A/G polymorphism is not associated with susceptibility to rheumatoid arthritis in Caucasians [meta-analysis]

  9. Observed no association between the MHC2TA or FCRL3 (show FCRL3 Antibodies) SNPs and rheumatoid arthritis in Mexican patients.

  10. CIITA acts as a general restriction factor against HIV-1 not only in T cells but also in myeloid cells.

Class II, Major Histocompatibility Complex, Transactivator (CIITA) Antigen Profile

Protein Summary

This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the 'master control factor' for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction.

Gene names and symbols associated with CIITA

  • class II, major histocompatibility complex, transactivator (CIITA) antibody
  • class II major histocompatibility complex transactivator (CIITA) antibody
  • MHC class II transactivator (LOC710761) antibody
  • class II, major histocompatibility complex, transactivator (ciita) antibody
  • MHC class II transactivator (LOC100443575) antibody
  • class II transactivator (Ciita) antibody
  • MHC class II transactivator (LOC100736732) antibody
  • class II, major histocompatibility complex, transactivator (Ciita) antibody
  • C2TA antibody
  • CIITA antibody
  • CIITAIV antibody
  • EG669998 antibody
  • Gm9475 antibody
  • Mhc2ta antibody
  • NLRA antibody

Protein level used designations for CIITA

class II, major histocompatibility complex, transactivator , class II transactivator-like , class II transactivator , MHC class II transactivator-like , MHC class II transactivator , MHC class II transactivator type III , NLR family, acid domain containing , nucleotide-binding oligomerization domain, leucine rich repeat and acid domain containing , MHC class II transactivator type IV

GENE ID SPECIES
427676 Gallus gallus
453914 Pan troglodytes
508720 Bos taurus
710761 Macaca mulatta
100003537 Danio rerio
100056546 Equus caballus
100338894 Oryctolagus cuniculus
100402996 Callithrix jacchus
100443575 Pongo abelii
12265 Mus musculus
100736732 Sus scrofa
4261 Homo sapiens
85483 Rattus norvegicus
490008 Canis lupus familiaris
Selected quality suppliers for anti-Class II, Major Histocompatibility Complex, Transactivator (CIITA) Antibodies
Did you look for something else?